ConductScience.org, home

Paper42827554PubMed

The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability.

Shi G and 6 others. Front Oncol, 2026.

Cite this record

ConductScience Library. The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability. Papers, record 42827554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42827554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability.
Journal
Front Oncol
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-05

Source PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shi GGengsheng
2Wu YYanyan
3Wang YYingying
4Wang SSuyu
5Xiang WWan
6Yin WWenqin
7Li RRuirui

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137524875The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis.Exp Mol Med2023https://conductscience.org/library/papers/37524875PubMed
231477831UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.Oncogene2020https://conductscience.org/library/papers/31477831PubMed
339183237Structural basis for allosteric regulation of human phosphofructokinase-1.Nat Commun2024https://conductscience.org/library/papers/39183237PubMed
434903602PKM2 Is Essential for Bladder Cancer Growth and Maintenance.Cancer Res2022https://conductscience.org/library/papers/34903602PubMed
522056988Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.Nature2011https://conductscience.org/library/papers/22056988PubMed
636899022Phosphoglycerate dehydrogenase activates PKM2 to phosphorylate histone H3T11 and attenuate cellular senescence.Nat Commun2023https://conductscience.org/library/papers/36899022PubMed
734355179Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.RSC Med Chem2021https://conductscience.org/library/papers/34355179PubMed
838720298ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment.Mol Cancer2024https://conductscience.org/library/papers/38720298PubMed
938762193Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation.Cancer Lett2024https://conductscience.org/library/papers/38762193PubMed
1033201207Bladder Cancer: A Review.JAMA2020https://conductscience.org/library/papers/33201207PubMed
1140451468UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma.Free Radic Biol Med2025https://conductscience.org/library/papers/40451468PubMed
1235973989DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35973989PubMed
1339027256KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2.Acta Pharm Sin B2024https://conductscience.org/library/papers/39027256PubMed
1440178292RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40178292PubMed
1534272515Cancer metabolism: looking forward.Nat Rev Cancer2021https://conductscience.org/library/papers/34272515PubMed
1636371026Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics.Semin Cancer Biol2022https://conductscience.org/library/papers/36371026PubMed
1740691601UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression.Cancer Cell Int2025https://conductscience.org/library/papers/40691601PubMed
1833991457The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.Cancer Commun (Lond)2021https://conductscience.org/library/papers/33991457PubMed
1939419941USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma.Cell Oncol (Dordr)2024https://conductscience.org/library/papers/39419941PubMed
2038385089USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma.Int J Biol Sci2024https://conductscience.org/library/papers/38385089PubMed

See all 36 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42827554

GET https://conductscience.org/api/papers/v1/42827554/references?page=2